Ropinirole Tablets Recalled Due to Manufacturing Quality Violations
Accord Healthcare is recalling Ropinirole 5mg tablets due to Current Good Manufacturing Practice (CGMP) deviations identified during an FDA inspection. The recall affects 5,112 bottles distributed in the United States, Puerto Rico, and Canada.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II precautionary recall due to CGMP deviations with no reported illnesses or injuries. Manufacturing quality violations without documented adverse events warrant a Moderate severity rating per the rubric.
Plain-English summary
Accord Healthcare, Inc. is recalling Ropinirole (ropinirole hydrochloride) 5mg tablets due to Current Good Manufacturing Practice (CGMP) deviations discovered during a U.S. Food and Drug Administration inspection.
The recall affects 5,112 bottles distributed across three batches: P2104150 and P2104151 (expiration 6/30/2023), and P2202065 (expiration 3/31/2024). The product was distributed to patients in the United States, Puerto Rico, and Canada.
Patients who have been dispensed ropinirole from the affected batches should contact their pharmacist or healthcare provider to discuss their medication. Patients should not stop taking their medication without consulting a healthcare professional, as abrupt discontinuation may cause harm. Verify the batch number on your medication bottle against the recalled batch numbers.
The recalled product
- Product
- ROPINIROLE (ROPINIROLE)
- Brand
- ROPINIROLE
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug
- Hazard
- cgmp-violation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Batches: P2104150
- P2104151
- Exp. Date 6/30/2023
- P2202065
- Exp. Date 3/31/2024
UPCs (1)
- 316729238014
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · ROPINIROLE
- HighFDA Recalls Ropinirole 3mg Tablets due to CGMP Deviations
FDA (Drugs) · 2023-03-08
- ModerateRopinirole Tablets Recalled by Accord Healthcare Following FDA Inspection
FDA (Drugs) · 2023-03-08
- HighRopinirole tablets recalled due to manufacturing practice deviations
FDA (Drugs) · 2023-03-08
- HighRopinirole tablets recalled due to FDA manufacturing compliance deviations
FDA (Drugs) · 2023-03-08
- ModerateRopinirole Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27